Global Oncology Academy

Weighing the Burden of Myelosuppression in SCLC

Weighing the Burden of Myelosuppression in SCLC

Learn more about the impact of myelosuppression among chemotherapy-treated patients with small-cell lung cancer.

  • Overview

    Current treatment options have led to several challenges, one of them being myelosuppression. How can this impact quality of life for patients with small-cell lung cancer? Dr. Jacob Sands discusses the burden of chemotherapy-induced myelosuppression with Dr. Jared Weiss, Professor of Medicine in the Division of Oncology in the UNC Lineberger Comprehensive Cancer Center.



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free